China has become the #2 pharmaceutical market years ahead of projections and continues to be the fastest growing market in the world. China is $50 billion dollars a year into life science and healthcare development through over 160 government funding programs. VC investment, M&A transactions and cross-border partnering deals in China were all up significantly in 2012.
ChinaBio® Today focuses exclusively on the rapidly evolving life science industry in China, including biotech, pharma, medical device, diagnostics, services and tools. From our offices in Shanghai and San Diego, our industry analysts provide daily news, commentary and analysis on public and private China life science companies, as well as events and global issues affecting the China market.
Visit: ChinaBio Today (http://www.chinabiotoday.com)
ChinaBio LLC (http://www.chinabiollc.com)
I enjoy corporate strategy especially the influence of strategic choices on stock performance and corporate earnings. Good strategic choices influence customer choices, corporate relationships and the quality of earnings. That's the focus of my curiosity and optical lens through which I write and read articles.
I am a graduate of the Carlson School of Management with an MBA in Finance and Strategic Management. My other interests are business development, working with small businesses and cycling.
How may I help you?